Frontiers in Immunology | Cancer Immunity and Immunotherapy

Correction

Published on 31 Jan 2025

Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma

in Cancer Immunity and Immunotherapy

Chengcheng Zhang
Linling Wang
Qianzhen Zhang
Junjie Shen
Xia Huang
Meiling Wang
Yi Huang
Jun Chen
Yanmin Xu
Wenxu Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1548247

349 views

Original Research

Published on 30 Jan 2025

Disulfidptosis as a key regulator of glioblastoma progression and immune cell impairment

in Cancer Immunity and Immunotherapy

Yifu Shu
Jing Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1526296

598 views

Original Research

Published on 30 Jan 2025

Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal adenocarcinoma

in Cancer Immunity and Immunotherapy

Metoboroghene O. Mowoe
Hisham Allam
Joshua Nqada
Marc Bernon
Karan Gandhi
Sean Burmeister
Urda Kotze
Miriam Kahn
Christo Kloppers
Suba Dharshanan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1494446

689 views

Original Research

Published on 30 Jan 2025

Correlations between primary tumour location, biomarkers of inflammation and lung injury, and postoperative pulmonary complications in patients underwent laparoscopic colorectomy: a propensity score matched analysis of 300 patients

in Cancer Immunity and Immunotherapy

Hui-xian Li
Li Che
Yuan Li
Tai-hang Wang
Fang-di Min
Lei Xu
Meng Wang
Zhao-xu Zheng
Shi-ning Qu
Fei Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1546167

430 views

Original Research

Published on 30 Jan 2025

Concentration-dependent effects of immunomodulatory cocktails on the generation of leukemia-derived dendritic cells, DCleu mediated T-cell activation and on-target/off-tumor toxicity

in Cancer Immunity and Immunotherapy

Hazal Aslan Rejeski
Anne Hartz
Elias Rackl
Lin Li
Christoph Schwepcke
Kai Rejeski
Christoph Schmid
Andreas Rank
Jörg Schmohl
Doris Kraemer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1527961

675 views

Review

Published on 30 Jan 2025

cGAS/STING signaling pathway in gynecological malignancies: From molecular mechanisms to therapeutic values

in Cancer Immunity and Immunotherapy

Danyang Zhang
Bingxue Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1525736

1,055 views

Systematic Review

Published on 30 Jan 2025

Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Xinyu Zhang
Bei Zhang
Danfei Li
Yunchao Yang
Sen Lin
Ruiqi Zhao
Yijia Li
Lisheng Peng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1528084

629 views

Correction

Published on 30 Jan 2025

Corrigendum: Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer

in Cancer Immunity and Immunotherapy

Qinyuan Gong
Rongzhen Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1560546

431 views

Original Research

Published on 30 Jan 2025

Development and validation of a nomogram for predicting immune-mediated colitis in lung cancer patients treated with immune checkpoint inhibitors: a retrospective cohort study in China

in Cancer Immunity and Immunotherapy

Qianjie Xu
Xiaosheng Li
Yuliang Yuan
Guangzhong Liang
Zuhai Hu
Wei Zhang
Ying Wang
Haike Lei

Frontiers in Immunology

doi 10.3389/fimmu.2025.1510053

673 views

Review

Published on 30 Jan 2025

NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance

in Cancer Immunity and Immunotherapy

Shaoyan Shi
Xuehai Ou
Chao Liu
Rui Li
Qianjin Zheng
Leiming Hu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1518664

777 views

Original Research

Published on 30 Jan 2025

Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer

in Cancer Immunity and Immunotherapy

Ying Ye
Yi Huang
Jianbo Pan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1538071

582 views

Original Research

Published on 30 Jan 2025

Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer

in Cancer Immunity and Immunotherapy

Yasunobu Mano
Yuka Igarashi
Keisuke Komori
Itaru Hashimoto
Hayato Watanabe
Kosuke Takahashi
Kazuki Kano
Hirohito Fujikawa
Takanobu Yamada
Hidetomo Himuro

Frontiers in Immunology

doi 10.3389/fimmu.2025.1521278

699 views

Original Research

Published on 30 Jan 2025

Preoperative assessment of liver regeneration using T1 mapping and the functional liver imaging score derived from Gd-EOB-DTPA-enhanced magnetic resonance for patient with hepatocellular carcinoma after hepatectomy

in Cancer Immunity and Immunotherapy

Qian Li
Tong Zhang
Shan Yao
Feifei Gao
Lisha Nie
Hehan Tang
Bin Song
Yi Wei

Frontiers in Immunology

doi 10.3389/fimmu.2025.1516848

489 views

Original Research

Published on 30 Jan 2025

Deregulated methylation and expression of PCDHGB7 in patients with non-small cell lung cancer: a novel prognostic and immunological biomarker

in Cancer Immunity and Immunotherapy

Yue Yuan
Xin Nie
Jiayi Gao
Yumeng Tian
Liuer He
Xue Wang
Ping Zhang
Junling Ma
Lin Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1516628

703 views

Review

Published on 29 Jan 2025

Vaccines for cancer interception in familial adenomatous polyposis

in Cancer Immunity and Immunotherapy

David E. Johnson
Mary L. Disis

Frontiers in Immunology

doi 10.3389/fimmu.2025.1525157

573 views

Review

Published on 29 Jan 2025

Unlocking the secrets of the immunopeptidome: MHC molecules, ncRNA peptides, and vesicles in immune response

in Cancer Immunity and Immunotherapy

Arpita Balakrishnan
Gabriela Winiarek
Olga Hołówka
Jakub Godlewski
Agnieszka Bronisz

Frontiers in Immunology

doi 10.3389/fimmu.2025.1540431

723 views

Navigation group

Articles

Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma

Disulfidptosis as a key regulator of glioblastoma progression and immune cell impairment

Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal adenocarcinoma

Correlations between primary tumour location, biomarkers of inflammation and lung injury, and postoperative pulmonary complications in patients underwent laparoscopic colorectomy: a propensity score matched analysis of 300 patients

Concentration-dependent effects of immunomodulatory cocktails on the generation of leukemia-derived dendritic cells, DCleu mediated T-cell activation and on-target/off-tumor toxicity

cGAS/STING signaling pathway in gynecological malignancies: From molecular mechanisms to therapeutic values

Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

Corrigendum: Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer

Development and validation of a nomogram for predicting immune-mediated colitis in lung cancer patients treated with immune checkpoint inhibitors: a retrospective cohort study in China

NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance

Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer

Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer

Preoperative assessment of liver regeneration using T1 mapping and the functional liver imaging score derived from Gd-EOB-DTPA-enhanced magnetic resonance for patient with hepatocellular carcinoma after hepatectomy

Deregulated methylation and expression of PCDHGB7 in patients with non-small cell lung cancer: a novel prognostic and immunological biomarker

Vaccines for cancer interception in familial adenomatous polyposis

Unlocking the secrets of the immunopeptidome: MHC molecules, ncRNA peptides, and vesicles in immune response